Global Nuclear Imaging Market 2017-2021
SKU ID : TNV-11174649 | Publishing Date : 09-Aug-2017 | No. of pages : 117
Detailed TOC of Global Nuclear Imaging Market 2017-2021
Table of ContentsPART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market overview
• Five forces analysis
PART 06: Market segmentation by application
• Oncology
• Cardiology
• Neurology
• Others
PART 07: Market segmentation by product
• Standalone PET nuclear imaging
• Standalone SPECT nuclear imaging
• Hybrid nuclear imaging
PART 08: Market segmentation by end-user
• Hospitals
• Diagnostic centers
• Research centers
PART 09: Geographical segmentation
• Nuclear imaging market in Americas
• Nuclear imaging market in EMEA
• Nuclear imaging market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
• Market drivers
• Market challenges
PART 12: Market trends
• Emergence of time of flight (TOF) nuclear imaging systems
• Growing focus on developing PET/MRI hybrid imaging systems
• Vendors' focus on emerging economies
• Growing focus on cyclotron-based production
• Advances in radionanomedicine
PART 13: Vendor landscape
• Competitive scenario
• Key news
PART 14: Key vendor analysis
• Digirad
• GE Healthcare
• Mediso
• Koninklijke Philips
• Siemens Healthcare
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Global nuclear imaging market 2016-2021 ($ millions)
Exhibit 02: Five forces analysis
Exhibit 03: Global nuclear imaging market by application 2016 (%)
Exhibit 04: Global nuclear imaging market by product 2016 ($ millions)
Exhibit 05: Global nuclear imaging market by product 2016-2021 ($ millions)
Exhibit 06: Global nuclear imaging market by product 2016-2021 (%)
Exhibit 07: Global nuclear imaging market by product 2016 and 2021 (%)
Exhibit 08: Global nuclear imaging market by product 2016 and 2021 ($ millions)
Exhibit 09: Global nuclear imaging market by product 2016 (%)
Exhibit 10: Nuclear imaging market by product type 2016
Exhibit 11: Snapshot of global PET nuclear imaging market 2016
Exhibit 12: Global standalone PET nuclear imaging market 2016-2021 ($ millions)
Exhibit 13: Snapshot of global SPECT nuclear imaging market 2016
Exhibit 14: Global standalone SPECT nuclear imaging market 2016-2021 ($ millions)
Exhibit 15: Snapshot of global hybrid nuclear imaging market 2016
Exhibit 16: Global hybrid nuclear imaging market 2016-2021 ($ millions)
Exhibit 17: Global nuclear imaging market by end-users 2016 (%)
Exhibit 18: Global nuclear imaging market by geography 2016
Exhibit 19: Global nuclear imaging market by geography 2016-2021 ($ millions)
Exhibit 20: Global nuclear imaging market by geography 2016-2021 (%)
Exhibit 21: Global nuclear imaging market by geography 2016 and 2021 ($ millions)
Exhibit 22: Global nuclear imaging market by geography 2016 and 2021 (%)
Exhibit 23: Nuclear imaging market in Americas 2016-2021 ($ millions)
Exhibit 24: Nuclear imaging market in EMEA 2016-2021 ($ millions)
Exhibit 25: Nuclear imaging market in APAC 2016-2021 ($ millions)
Exhibit 26: Advantages of cyclotron-based radioisotopes production
Exhibit 27: Competitive structure analysis of global nuclear imaging market 2016
Exhibit 28: Digirad: Key highlights
Exhibit 29: Digirad: Strength assessment
Exhibit 30: Digirad: Strategy assessment
Exhibit 31: Digirad: Opportunity assessment
Exhibit 32: GE Healthcare: Key highlights
Exhibit 33: GE Healthcare strength assessment
Exhibit 34: GE Healthcare strategy assessment
Exhibit 35: GE Healthcare opportunity assessment
Exhibit 36: Mediso: Key highlights
Exhibit 37: Mediso: Strength assessment
Exhibit 38: Mediso: Strategy assessment
Exhibit 39: Mediso: Opportunity assessment
Exhibit 40: Koninklijke Philips: Key highlights
Exhibit 41: Koninklijke Philips: Strength assessment
Exhibit 42: Koninklijke Philips: Strategy assessment
Exhibit 43: Koninklijke Philips: Opportunity assessment
Exhibit 44: Siemens Healthcare: Key highlights
Exhibit 45: Siemens Healthcare: Strength assessment
Exhibit 46: Siemens Healthcare: Strategy assessment
Exhibit 47: Siemens Healthcare: Opportunity assessment